Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old

•About 42% of infants who received MenACWY-CRM had an indicated high-risk condition.•After vaccination, 29% had an incident condition in emergency/hospital visits.•Fever and upper respiratory infections were most common.•Incident emergency/hospital visit rates were comparable to background rates.•Th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2020-01, Vol.38 (2), p.228-234
Hauptverfasser:	Becerra-Culqui, Tracy A., Sy, Lina S., Ackerson, Bradley K., Slezak, Jeff M., Luo, Yi, Fischetti, Christine A., Ohadike, Yvonne U., Curina, Carlo, Pellegrini, Michele, Solano, Zendi, Tartof, Sara Y., Tseng, Hung Fu
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Asplenia Automation Clinical trials Codes Confidence intervals Conjugates Demographics Disease Electronic health records Electronic medical records Emergency medical services Emergency Service, Hospital - statistics & numerical data Epidemics Female Fever HIV Hospitalization Hospitalization - statistics & numerical data Hospitals Human immunodeficiency virus Humans Immunization Infant Infants Male Meningococcal conjugate vaccine Meningococcal disease Meningococcal Infections - prevention & control Meningococcal Vaccines - administration & dosage Meningococcal Vaccines - adverse effects Observational studies Observational study Pre-existing conditions Preschool children Respiratory system Risk Safety Thymic hypoplasia Toddlers Vaccination Vaccines Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!